Compound ID | 526
Synonym(s): MC-02,595 | D-orn-D-hPhe-3NHQ
Class: Efflux pump inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Permeates bacteria to other antibiotic compounds; pseudomonal infections |
| Combined with other compounds: | Tested with Levofloxacin and results were positive |
| Institute where first reported: | Microcide Pharmaceuticals (Essential Therapeutics (Ceased)); Daiichi Sankyo Pharmaceutical, Japan |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Essential Therapeutics closed down in 2004 |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/273137022 |
| Citation: | https://www.sciencedirect.com/science/article/pii/S0960894X03005560?via%3Dihub |